Bey P, Danzin C, Van Dorsselaer V, Mamont P, Jung M, Tardif C
J Med Chem. 1978 Jan;21(1):50-5. doi: 10.1021/jm00199a009.
Fourteen structural analogues of ornithine were synthesized and evaluated as inhibitors of preparations of the enzyme L-ornithine carboxylase (ODC) (E.C. 4.1.1.17) obtained from rat liver, rat hepatoma cells in culture, or bull prostate. The synthesis of these compounds was achieved either via a Bucherer type reaction or via alkylation of carbanions derived from ethyl acetamidocyanoacetate, methyl isocyanoacetate, benzyl alpha-isocyanopropionate, methylbenzaldimine alanate, and the azlactone derivative of ornithuric acid. (+)-alpha-Methylornithine, which was assigned the L configuration on the basis of rotational criteria, was found to be the most potent reversible inhibitor of ODC among the synthesized compounds. From the degree of inhibition of ODC activity in the presence of the various ornithine analogues, it has been possible to delineate some of the structural features of the substrate L-ornithine which are required for binding to the mammalian ODC active site.
合成了14种鸟氨酸的结构类似物,并将其作为从大鼠肝脏、培养的大鼠肝癌细胞或公牛前列腺中获得的L-鸟氨酸羧化酶(ODC)(E.C. 4.1.1.17)制剂的抑制剂进行评估。这些化合物的合成是通过布赫勒尔型反应或通过乙酰胺基氰基乙酸乙酯、异氰基乙酸甲酯、苄基α-异氰基丙酸酯、甲基苯基亚胺丙氨酸酯和鸟尿酸的恶唑烷酮衍生物衍生的碳负离子的烷基化来实现的。根据旋光标准被指定为L构型的(+)-α-甲基鸟氨酸被发现是合成化合物中最有效的ODC可逆抑制剂。从各种鸟氨酸类似物存在下ODC活性的抑制程度,可以描绘出底物L-鸟氨酸与哺乳动物ODC活性位点结合所需的一些结构特征。